查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1499492

Dydrogesterone市場：按類型、按應用分類 - 2024-2030 年全球預測

Dydrogesterone Market by Type (Dydrogesterone D5, Dydrogesterone D6), Application (Gynecological Diseases, Infertility) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年Dydrogesterone市場規模為5.6786億美元，2024年將達6.1812億美元，預計2030年將達到10.69億美元，複合年成長率為9.45%。

Dydrogesterone是一種合成激素，其化學結構和藥理作用與內源性黃體酮相似。它被歸類為孕激素，是一種用來模仿天然激素孕酮作用的藥物。Dydrogesterone具有很強的黃體素作用，因此非常適合黃體素缺乏症。它經常用於各種臨床環境，包括月經失調、黃體功能障礙引起的不孕症以及針對更年期症狀的荷爾蒙補充療法(HRT)。與其他合成黃體素藥物不同，Dydrogesterone在治療劑量下不會抑制排卵，因此當需要維持排卵週期時，它是首選。由於女性人口老化的加劇、生殖健康問題的普遍存在、醫療基礎設施的改善、醫療的進步以及政府對婦女健康的支持政策，Dydrogesterone市場正在見證成長。儘管成長前景良好，但嚴格的藥品核准法規、副作用和市場競爭等挑戰正在阻礙市場擴張。然而，開拓新的藥物輸送機制、引入具有成本效益的學名藥以及針對廣泛治療應用的聯合治療的研究為未來的市場成長提供了利潤豐厚的機會。

主要市場統計
基準年[2023] 56786萬美元
預測年份 [2024] 61812萬美元
預測年份 [2030] 10.69億美元
複合年成長率（%） 9.45%

區域洞察

美洲地Dydrogesterone市場呈現穩定的成長格局。人們對婦女健康問題的認知不斷提高，以及女性群體中子宮內膜異位症和月經等疾病的流行，增加了對荷爾蒙相關治療方案的需求。由於其完善的醫療保健基礎設施、大型製藥公司的存在以及支持性的法律規範，美國對該地區的市場成長做出了重大貢獻。除此之外，此類藥物的高購買力和保險覆蓋範圍正在支持地Dydrogesterone市場的強勁發展。由於荷爾蒙補充療法的廣泛接受和有利的醫療保健報銷政策，歐洲是歐洲/中東/非洲地Dydrogesterone市場的主要貢獻者。該地區成熟的醫療保健體係有助於其強大的市場地位。另一方面，中東和非洲地區由於醫療投資的增加和婦女生殖健康意識的逐漸普及，儘管其成長率低於歐洲，但仍顯示出成長潛力。亞太地區的Dydrogesterone市場預計成長率最高。推動這種擴張的因素包括婦科疾病發病率上升、勞動力中女性人數的增加、醫療基礎設施的改善以及對婦女健康問題的認知提高。尤其是中國和印度等國家的醫藥產業正在快速成長，這些國家由於人口眾多且醫療旅遊不斷增加而成為巨大的市場。

FPNV定位矩陣

FPNV 定位矩陣對於評估地Dydrogesterone市場供應商定位至關重要。此矩陣提供了對供應商的全面評估，並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對地Dydrogesterone市場供應商的當前狀態進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他關鍵指標。此外，該分析還提供了對該行業競爭性質的寶貴見解，包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對Dydrogesterone市場當前地位的全面評估使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 女性人口老化加劇和生殖健康問題普遍存在
      • 支持婦女健康的政府政策
      • 改善整個經濟領域的醫療基礎設施
    • 抑制因素
      • 生產地Dydrogesterone的成本很高。
    • 機會
      • 學名藥核准增加
      • 市場參與企業增加投資和擴張
    • 任務
      • 與Dydrogesterone藥物相關的嚴格監管核准流程
  • 市場區隔分析
    • 類型：DydrogesteroneD6在高精度分析和臨床試驗的優勢
    • 用途：Dydrogesterone在婦科疾病症狀緩解和荷爾蒙調節的重要應用
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章Dydrogesterone市場：依類型

  • DydrogesteroneD5
  • DydrogesteroneD6

第7章Dydrogesterone市場：依應用分類

  • 婦科疾病
  • 不孕症

第8章美洲地Dydrogesterone市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區Dydrogesterone市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲地Dydrogesterone市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 市場佔有率分析（2023）
  • FPNV定位矩陣（2023）
  • 競爭情境分析
    • Theramex 宣布同意從 Viatris 收購 Duphaston 和 Femoston 的歐洲權利
    • Aurisco的Auxiton（Dydrogesterone）獲得中國首個學名藥核准
    • 美國製藥大廠申請發布改良版藥物，用於治療子宮內膜異位症引起的骨盆腔疼痛
  • 戰略分析和建議

第12章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-144C638C9216

[189 Pages Report] The Dydrogesterone Market size was estimated at USD 567.86 million in 2023 and expected to reach USD 618.12 million in 2024, at a CAGR 9.45% to reach USD 1,069.00 million by 2030.

Dydrogesterone is a synthetic hormone similar in chemical structure and pharmacological effect to endogenous progesterone. It is classified as a progestin, which is a type of medication used to replicate the effects of the natural hormone progesterone. Dydrogesterone possesses a strong progestational effect, which makes it highly suitable for conditions related to progesterone deficiency. It is frequently employed in a variety of clinical situations, such as menstrual disorders, infertility owing to luteal insufficiency, and as part of hormone replacement therapy (HRT) for menopausal symptoms. Unlike some other synthetic progestins, dydrogesterone does not inhibit ovulation at therapeutic doses, making it a preferred option in cases where maintenance of ovulatory cycles is desired. The dydrogesterone market is exhibiting growth with an increasing elderly female population and prevalence of reproductive health issues, improved healthcare infrastructure, medical advancements, and supportive government policies for women's health. Despite the growth prospects, challenges such as stringent drug approval regulations, side effects, and competitive alternatives for dydrogesterone hinder the scope of the market. However, developing novel drug delivery mechanisms, introducing generic versions for cost-effectiveness, and investigating combination therapies for broader therapeutic applications present lucrative opportunities for future market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 567.86 million
Estimated Year [2024] USD 618.12 million
Forecast Year [2030] USD 1,069.00 million
CAGR (%) 9.45%

Regional Insights

The dydrogesterone market in the Americas is experiencing a steady growth pattern. The increase in awareness regarding women's health issues and the prevalence of conditions, including endometriosis and irregular menstrual cycles in the female population, bolster the demand for hormone-related treatment options. The United States is a significant contributor to market growth within this region owing to the well-established healthcare infrastructure, presence of major pharmaceutical companies, and supportive regulatory framework. This is coupled with a higher purchasing power and insurance coverage for such medications, aiding in the positive trajectory of the dydrogesterone market. Europe is a major contributor to the dydrogesterone market in the EMEA, with widespread acceptance of hormone replacement therapies and favorable healthcare reimbursement policies. The region's mature healthcare systems contribute to its strong market position. Meanwhile, the Middle East and Africa regions show potential for growth, albeit at a slower rate compared to Europe, due to increasing healthcare investments and the gradual spread of awareness regarding women's reproductive health. The market for dydrogesterone in the Asia-Pacific region is expected to experience the highest growth rate. Factors fueling this expansion include the rising incidence of gynecological disorders, an increase in the female working population, improving healthcare infrastructure, and growing awareness around women's health issues. Particularly, countries including China and India have burgeoning pharmaceutical sectors and represent considerable markets owing to their large populations and increasing medical tourism.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Dydrogesterone Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Increasing elderly female population and prevalence of reproductive health issues
      • Supportive government policies for women's health
      • Improved healthcare infrastructure across economies
    • Market Restraints
      • High costs associated with dydrogesterone production
    • Market Opportunities
      • Rising approval of generic dydrogesterone drugs
      • Growing investment and expansion by market players
    • Market Challenges
      • Stringent regulatory approval processes associated with dydrogesterone drugs
  • Market Segmentation Analysis
    • Type: Benefits of dydrogesterone d6 in highly precise analytical and clinical tests
    • Application: Significant applications of dydrogesterone for symptomatic relief and hormonal regulation in gynecological conditions
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Dydrogesterone Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Dydrogesterone Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Theramex Announces Agreement to Acquire the European Rights to Duphaston and Femoston From Viatris, Inc.

Theramex, a UK-based pharmaceutical company, has recently acquired rights for Duphaston (dydrogesterone) and Femoston (estradiol + dydrogesterone) from Viatris, Inc. across European markets. This strategic move, subject to regulatory and anti-trust clearances, aligns with Theramex's focus on women's health. [Published On: 2023-10-02]

Aurisco Gets Auxiton (Dydrogesterone) as First Generic Approval in China

Aurisco Pharmaceutical received China's NMPA Marketing Authorization Approval for Auxiton, a dydrogesterone oral dosage form, signaling its commitment to advancing women's health. The superior bioavailability and efficacy of Auxiton demonstrate Aurisco's focus on providing reliable luteal support for pregnancy and IVF treatments. [Published On: 2023-06-27]

US Pharma Giant Applies for Nod to Launch Tweaked Version of Drug for Pelvic Pain in Endometriosis

Abbott Laboratories is aiming to introduce an advanced dydrogesterone formulation to the Indian market, designed specifically for alleviating pelvic pain associated with endometriosis, affecting approximately 25 million women in India. On May 18, Abbott moved a step closer by applying to the Drugs Controller General of India (DCGI) for the requisite permissions to commence manufacturing and marketing the new 20 mg modified release dydrogesterone tablets, aligning with India's new drug and clinical trial regulations. This progressive variant aims to enhance the quality of life for those coping with this prevalent condition where endometrial-like tissue proliferates outside the uterine cavity. [Published On: 2023-05-20]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Dydrogesterone Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Dydrogesterone Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Adalvo Limited, Alembic Pharmaceuticals Limited, Axios Research, Clearsynth, Dr. D Pharma, Gufic Group, H & Care Incorp, Jagsonpal Pharmaceuticals Ltd., Mankind Pharma Limited, Medley Pharmaceuticals Ltd., Merck KGaA, Sandoo Pharmaceuticals and Chemcials Co.,Ltd., Santa Cruz Biotechnology, Inc., Simson Pharma Limited, Solitaire Pharmacia Private Limited, Somacare, Synokem Pharmaceuticals Ltd., Taj Pharmaceuticals Limited, Theramex, TLC Pharmaceutical Standards Ltd., Viatris Inc., VIVAN Life Sciences, and Zuventus Healthcare Limited.

Market Segmentation & Coverage

This research report categorizes the Dydrogesterone Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Dydrogesterone D5
    • Dydrogesterone D6
  • Application
    • Gynecological Diseases
    • Infertility
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing elderly female population and prevalence of reproductive health issues
      • 5.1.1.2. Supportive government policies for women's health
      • 5.1.1.3. Improved healthcare infrastructure across economies
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with dydrogesterone production
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising approval of generic dydrogesterone drugs
      • 5.1.3.2. Growing investment and expansion by market players
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory approval processes associated with dydrogesterone drugs
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Benefits of dydrogesterone d6 in highly precise analytical and clinical tests
    • 5.2.2. Application: Significant applications of dydrogesterone for symptomatic relief and hormonal regulation in gynecological conditions
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Dydrogesterone Market, by Type

  • 6.1. Introduction
  • 6.2. Dydrogesterone D5
  • 6.3. Dydrogesterone D6

7. Dydrogesterone Market, by Application

  • 7.1. Introduction
  • 7.2. Gynecological Diseases
  • 7.3. Infertility

8. Americas Dydrogesterone Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Dydrogesterone Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Dydrogesterone Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Theramex Announces Agreement to Acquire the European Rights to Duphaston and Femoston From Viatris, Inc.
    • 11.3.2. Aurisco Gets Auxiton (Dydrogesterone) as First Generic Approval in China
    • 11.3.3. US Pharma Giant Applies for Nod to Launch Tweaked Version of Drug for Pelvic Pain in Endometriosis
  • 11.4. Strategy Analysis & Recommendation

12. Competitive Portfolio

  • 12.1. Key Company Profiles
  • 12.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. DYDROGESTERONE MARKET RESEARCH PROCESS
  • FIGURE 2. DYDROGESTERONE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DYDROGESTERONE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DYDROGESTERONE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL DYDROGESTERONE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. DYDROGESTERONE MARKET DYNAMICS
  • FIGURE 7. GLOBAL DYDROGESTERONE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL DYDROGESTERONE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES DYDROGESTERONE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES DYDROGESTERONE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. DYDROGESTERONE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 20. DYDROGESTERONE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DYDROGESTERONE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DYDROGESTERONE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL DYDROGESTERONE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL DYDROGESTERONE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL DYDROGESTERONE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL DYDROGESTERONE MARKET SIZE, BY DYDROGESTERONE D5, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL DYDROGESTERONE MARKET SIZE, BY DYDROGESTERONE D5, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL DYDROGESTERONE MARKET SIZE, BY DYDROGESTERONE D6, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL DYDROGESTERONE MARKET SIZE, BY DYDROGESTERONE D6, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL DYDROGESTERONE MARKET SIZE, BY GYNECOLOGICAL DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL DYDROGESTERONE MARKET SIZE, BY GYNECOLOGICAL DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL DYDROGESTERONE MARKET SIZE, BY INFERTILITY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL DYDROGESTERONE MARKET SIZE, BY INFERTILITY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. AMERICAS DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 20. AMERICAS DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 21. AMERICAS DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 22. AMERICAS DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 23. AMERICAS DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 24. AMERICAS DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 25. ARGENTINA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 26. ARGENTINA DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 27. ARGENTINA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 28. ARGENTINA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 29. BRAZIL DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 30. BRAZIL DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 31. BRAZIL DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 32. BRAZIL DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 33. CANADA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 34. CANADA DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 35. CANADA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 36. CANADA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 37. MEXICO DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 38. MEXICO DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 39. MEXICO DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 40. MEXICO DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 41. UNITED STATES DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 42. UNITED STATES DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 43. UNITED STATES DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 44. UNITED STATES DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 45. UNITED STATES DYDROGESTERONE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 46. UNITED STATES DYDROGESTERONE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 54. AUSTRALIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 56. AUSTRALIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 57. CHINA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. CHINA DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. CHINA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 60. CHINA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 61. INDIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 62. INDIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 63. INDIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 64. INDIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 65. INDONESIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 66. INDONESIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 67. INDONESIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 68. INDONESIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 69. JAPAN DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 70. JAPAN DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 71. JAPAN DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 72. JAPAN DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 73. MALAYSIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 74. MALAYSIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 75. MALAYSIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 76. MALAYSIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. PHILIPPINES DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 80. PHILIPPINES DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 81. SINGAPORE DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 82. SINGAPORE DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 83. SINGAPORE DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 84. SINGAPORE DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. SOUTH KOREA DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 88. SOUTH KOREA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 89. TAIWAN DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. TAIWAN DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. TAIWAN DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 92. TAIWAN DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 93. THAILAND DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 94. THAILAND DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 95. THAILAND DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 96. THAILAND DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 97. VIETNAM DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. VIETNAM DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. VIETNAM DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 100. VIETNAM DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 107. DENMARK DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 108. DENMARK DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 109. DENMARK DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 110. DENMARK DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 111. EGYPT DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 112. EGYPT DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 113. EGYPT DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 114. EGYPT DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 115. FINLAND DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. FINLAND DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. FINLAND DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 118. FINLAND DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 119. FRANCE DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 120. FRANCE DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 121. FRANCE DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 122. FRANCE DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 123. GERMANY DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 124. GERMANY DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 125. GERMANY DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 126. GERMANY DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 127. ISRAEL DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. ISRAEL DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. ISRAEL DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 130. ISRAEL DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 131. ITALY DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 132. ITALY DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 133. ITALY DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 134. ITALY DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 136. NETHERLANDS DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 138. NETHERLANDS DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 139. NIGERIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. NIGERIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. NIGERIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 142. NIGERIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 143. NORWAY DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 144. NORWAY DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 145. NORWAY DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. NORWAY DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. POLAND DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 148. POLAND DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 149. POLAND DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 150. POLAND DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 151. QATAR DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. QATAR DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. QATAR DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 154. QATAR DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 155. RUSSIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. RUSSIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. RUSSIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 158. RUSSIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 160. SAUDI ARABIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 162. SAUDI ARABIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 164. SOUTH AFRICA DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 166. SOUTH AFRICA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 167. SPAIN DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 168. SPAIN DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 169. SPAIN DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 170. SPAIN DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 171. SWEDEN DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. SWEDEN DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. SWEDEN DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 174. SWEDEN DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 176. SWITZERLAND DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 178. SWITZERLAND DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 179. TURKEY DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 180. TURKEY DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 181. TURKEY DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 182. TURKEY DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. UNITED KINGDOM DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 190. UNITED KINGDOM DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 191. DYDROGESTERONE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. DYDROGESTERONE MARKET, FPNV POSITIONING MATRIX, 2023